uniQure (QURE) Stock Forecast & Price Target

QURE price $25.65 +0.68 +2.72%

Ticker
QURE
Price
$25.65
Change
+0.68 +2.72%
Market cap ?
$1.78B
P/E ?
-6.18
Forward P/E ?
24.53
Dividend yield ?
0.00%
Beta ?
0.94
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
58
Quality
33
Growth
98

Stocklytics score rationale: value 58, quality 33, growth 98.

Financials

2016201720182019202020212022202320242025
250980001310700011284000728100037514000524002000106483000158430002711900016098000

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntington’s disease. The company also…

Fair value

QURE fair value $26.86. Price $25.65. Price is about fair value.

Below fair value, but more expensive than usual. A smaller discount than on 86% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare QURE

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.92—6.17M
2026-07-29-1.22-0.825.84M5.45M
2026-05-05-0.85-0.883.56M5.20M
2026-03-02-0.56-0.935.57M5.33M
2025-11-10-1.38-0.853.70M4.84M
2025-07-29-0.69-0.895.26M4.63M
2025-05-09-0.82-1.071.57M5.90M
2025-02-27-1.50-0.605.22M18.45M
2024-11-05-0.91-1.122.29M18.33M
2024-08-01-1.16-1.2411.13M6.79M
2024-05-07-1.36-1.318.48M6.23M
2024-02-28-1.53-1.546.69M5.59M
2023-11-07-1.88-1.491.41M6.11M
2023-08-01-1.442.972.42M207.71M
2023-05-09-1.63-1.025.33M28.25M
2023-02-270.15-0.89102.75M19.42M
2022-11-02-1.02-1.111.45M3.48M
2022-08-08-0.84-0.96497.00K10.19M
2022-05-02-1.00-0.671.79M17.66M
2022-02-250.17-0.8157.69M10.75M
2021-10-25-0.79-1.001.99M2.52M
2021-07-268.512.96463.87M2.52M
2021-05-10-0.91-0.89454.00K438.52K
2021-03-01-0.01-0.7834.09M—
2020-10-27-1.211.701.79M2.68M
2020-07-30-0.96-0.481.53M1.07M
2020-04-29-0.63-0.86104.00K138.67K
2020-03-02-0.97-0.782.62M79.08K
2019-10-28-0.58-0.831.05M1.46M
2019-07-29-0.83-0.752.47M2.24M
2019-04-29-0.74-0.661.14M1.09M
2019-02-28-0.59-0.661.61M1.80M
2018-11-06-0.59-0.633.15M3.31M
2018-08-08-0.57-0.623.05M3.26M
2018-04-30-0.59-0.743.48M4.36M
2018-03-14-0.91-0.682.58M2.94M
2017-11-01-0.40-0.652.26M3.56M
2017-08-08-0.83-0.864.94M4.70M
2017-05-09-0.80-0.643.32M2.74M
2017-03-15-0.58-0.529.05M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-02Kapusta Matthew CBuy21.08K$19.39408.78K
2026-07-02Kapusta Matthew CSell9.20K$44.43408.76K
2026-07-02Kapusta Matthew CSell4.28K$45.43194.53K
2026-07-02Kapusta Matthew CSell7.60K$45.89348.76K
2026-07-02Kapusta Matthew CSell21.08K$19.39408.78K
2026-06-30Abi-Saab WalidBuy10.00K$5.5955.90K
2026-06-30Abi-Saab WalidSell10.00K$46.46464.60K
2026-06-30Abi-Saab WalidSell20.00K$46.40928.00K
2026-06-30Abi-Saab WalidSell10.00K$5.5955.90K
2026-06-30Kaye JackBuy17.06K$20.18344.27K
2026-06-30Kaye JackBuy4.11K$37.00151.96K
2026-06-30Kaye JackSell17.06K$46.43792.10K
2026-06-30Kaye JackSell4.11K$46.49190.93K
2026-06-30Kaye JackSell17.06K$20.18344.27K
2026-06-30Kaye JackSell4.11K$37.00151.96K
2026-06-26Abi-Saab WalidSell1.43K$46.8667.20K
2026-06-25Kapusta Matthew CBuy28.72K$31.71910.58K
2026-06-25Kapusta Matthew CSell28.72K$50.021.44M
2026-06-25Kapusta Matthew CSell28.72K$31.71910.58K
2026-06-24Kapusta Matthew CBuy4.13K$31.71130.90K
2026-06-24Kapusta Matthew CSell6.70K$50.00334.80K
2026-06-24Kapusta Matthew CSell4.13K$31.71130.90K
2026-06-18Kapusta Matthew CBuy4.66K$31.71147.64K
2026-06-18Kapusta Matthew CSell4.66K$50.00232.80K
2026-06-18Kapusta Matthew CSell37.02K$50.001.85M
2026-06-18Kapusta Matthew CSell4.66K$31.71147.64K
2026-06-17Kapusta Matthew CBuy62.58K$19.391.21M
2026-06-17Kapusta Matthew CSell23.98K$42.611.02M
2026-06-17Kapusta Matthew CSell6.02K$43.70263.21K
2026-06-17Kapusta Matthew CSell32.58K$45.021.47M
2026-06-17Kapusta Matthew CSell56.93K$43.432.47M
2026-06-17Kapusta Matthew CSell33.33K$45.011.50M
2026-06-17Kapusta Matthew CSell11.59K$48.65563.61K
2026-06-17Kapusta Matthew CSell62.58K$19.391.21M
2026-06-17Balachandran MadhavanBuy6.39K$19.39123.90K
2026-06-17Balachandran MadhavanSell5.29K$47.08249.29K
2026-06-17Balachandran MadhavanBuy5.29K$31.71167.90K
2026-06-17Balachandran MadhavanSell4.70K$43.66205.20K
2026-06-17Balachandran MadhavanSell1.69K$42.6071.99K
2026-06-17Balachandran MadhavanSell5.29K$31.71167.90K
2026-06-17Balachandran MadhavanSell6.39K$19.39123.90K
2026-06-17Kaye JackBuy5.29K$31.71167.90K
2026-06-17Kaye JackSell5.29K$42.57225.41K
2026-06-17Kaye JackSell5.29K$31.71167.90K
2026-06-15Balachandran MadhavanBuy10.00K$8.4984.90K
2026-06-15Balachandran MadhavanSell10.00K$27.85278.50K
2026-06-15Balachandran MadhavanSell10.00K$8.4984.90K
2026-06-15Potts JeannetteSell5.24K$27.67144.91K
2026-06-11Meek David D.Sell1.99K$27.0653.93K
2026-06-11Gut RobertSell2.73K$27.0673.77K
2026-06-11O'Keefe KylieSell15.94K$27.06431.23K
2026-06-11Springhorn Jeremy P.Sell1.99K$27.0653.93K
2026-06-11POST LEONARD ESell1.99K$27.0653.93K
2026-06-11Kaye JackSell1.99K$27.0653.93K
2026-06-11Jacques Rachelle SuzanneSell1.99K$27.0653.93K
2026-06-11Balachandran MadhavanSell1.99K$27.0653.93K
2026-06-10Meek David D.Buy7.55K——
2026-06-10Meek David D.Buy13.98K$26.82374.94K
2026-06-10Gut RobertBuy2.65K$16.0442.43K
2026-06-10Gut RobertBuy7.55K——
2026-06-10Gut RobertSell2.65K$26.0768.96K
2026-06-10Gut RobertSell3.13K$26.0381.40K
2026-06-10Gut RobertSell1.78K$26.0546.37K
2026-06-10Gut RobertBuy13.98K$26.82374.94K
2026-06-10Gut RobertSell2.65K$16.0442.43K
2026-06-10Springhorn Jeremy P.Buy7.55K——
2026-06-10Springhorn Jeremy P.Buy13.98K$26.82374.94K
2026-06-10POST LEONARD EBuy7.55K——
2026-06-10POST LEONARD EBuy13.98K$26.82374.94K
2026-06-10Kaye JackBuy7.55K——
2026-06-10Kaye JackBuy13.98K$26.82374.94K
2026-06-10Jacques Rachelle SuzanneBuy7.55K——
2026-06-10Jacques Rachelle SuzanneBuy13.98K$26.82374.94K
2026-06-10Balachandran MadhavanBuy7.55K——
2026-06-10Balachandran MadhavanBuy13.98K$26.82374.94K
2026-06-03Kaye JackBuy2.65K$16.0442.43K
2026-06-03Kaye JackSell2.65K$30.0179.38K
2026-06-03Kaye JackSell2.65K$16.0442.43K
2026-05-08Abi-Saab WalidBuy25.00K$5.59139.75K
2026-05-08Abi-Saab WalidSell25.00K$25.10627.50K
2026-05-08Abi-Saab WalidSell20.00K$25.00500.00K
2026-05-08Abi-Saab WalidSell25.00K$5.59139.75K
2026-03-04O'Keefe KylieBuy19.80K——
2026-03-04O'Keefe KylieBuy31.90K$9.04288.38K
2026-03-04Kapusta Matthew CBuy70.60K——
2026-03-04Kapusta Matthew CSell14.58K$9.06132.10K
2026-03-04Kapusta Matthew CBuy113.80K$9.041.03M
2026-03-04Abi-Saab WalidBuy41.70K——
2026-03-04Abi-Saab WalidSell808$9.067.32K
2026-03-04Abi-Saab WalidBuy67.20K$9.04607.49K
2026-03-04Potts JeannetteBuy35.40K——
2026-03-04Potts JeannetteSell3.41K$9.0630.91K
2026-03-04Potts JeannetteBuy57.20K$9.04517.09K
2026-03-04KLEMT CHRISTIANBuy39.60K——
2026-03-04KLEMT CHRISTIANSell12.00K$9.06108.72K
2026-03-04KLEMT CHRISTIANBuy63.90K$9.04577.66K
2026-03-02Kapusta Matthew CSell34.44K$9.95342.65K
2026-03-02KLEMT CHRISTIANSell12.53K$9.95124.69K
2026-03-02Potts JeannetteSell8.58K$9.9585.35K
2026-03-02Abi-Saab WalidSell1.66K$9.9516.52K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 302, holders +42 vs prior quarter. Ownership 99.33%.

HolderSharesChangeChange %Value
AVORO CAPITAL ADVISORS LLC6.73M768.18K+12.89%309.88M
JPMORGAN CHASE & CO4.87M2.03M+71.55%230.81M
RTW INVESTMENTS, LP3.94M1.36M+52.40%181.55M
STATE STREET CORP2.90M643.31K+28.46%133.75M
ABERDEEN GROUP PLC2.85M-2.46M-46.33%131.18M
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.58M2.02M+359.07%118.73M
BLACKROCK, INC.1.88M144.00K+8.31%86.48M
ORBIMED ADVISORS LLC1.81M-328.66K-15.39%83.25M
CAPTION MANAGEMENT, LLC1.63M1.34M+458.16%74.97M
JANE STREET GROUP, LLC1.61M1.45M+889.24%74.18M
JENNISON ASSOCIATES LLC1.56M327.62K+26.55%71.92M
BOXER CAPITAL MANAGEMENT, LLC1.50M841.30K+127.08%69.24M
GOLDMAN SACHS GROUP INC1.48M212.72K+16.84%67.98M
TWO SIGMA INVESTMENTS, LP1.46M-1.21M-45.36%67.34M
TWO SEAS CAPITAL LP1.44M141.41K+10.88%66.39M
FMR LLC1.27M-473.74K-27.17%58.50M
MAK CAPITAL ONE LLC1.23M790.85K+179.25%56.75M
MPM BIOIMPACT LLC1.23M-143.38K-10.47%56.46M
MORGAN STANLEY1.07M700.52K+191.34%49.13M
CITADEL ADVISORS LLC1.00M595.63K+147.23%46.07M
VESTAL POINT CAPITAL, LP935.00K576.00K+160.45%43.07M
MAVERICK CAPITAL LTD925.38K227.74K+32.64%42.62M
CITADEL ADVISORS LLC910.34K505.77K+125.02%41.93M
FIERA CAPITAL CORP909.14K92.25K+11.29%41.88M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC900.00K00.00%41.45M

Forecast

Consensus Buy from 14 analysts. Average price target $52.18, +103.4% versus the current price. Low $28.00. High $80.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $52.18 for uniQure (QURE), 103.2% above the current price of $25.68. Of 14 analysts covering the stock, 12 rate it Buy or Strong Buy, 2 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

QURE price target

12-month price target
Low$28.00
Average$52.18
High$80.00

The average is 103.2% above the current price of $25.68.

Is uniQure a buy or sell?

Of 14 analysts, 12 rate uniQure Buy or Strong Buy, 2 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

uniQure earnings and revenue forecast

Analyst averages on file: 2026, EPS -3.88, revenue $23.24 million. 2027, EPS -3.02, revenue $118.62 million.

QURE score and fair value

The Stocklytics Score for QURE is 63 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

QURE forecast FAQs

What is the QURE price target?

$52.18 average, with a published range of $28.00 to $80.00.

Is uniQure a buy or sell?

The consensus is Buy from 14 analysts. This is not a recommendation.

What is the uniQure stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is -3.88. The average revenue estimate is $23.24 million.

What will QURE be worth in 2030?

No reliable forecast exists that far out.

When is uniQure's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: uniQure · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

uniQure (QURE) Stock Forecast & Price Target

QURE$25.65+0.68 +2.72%

$1.78B

Market Cap

-6.18

P/E

24.53

Forward P/E

63

Score

Price History